| 注册
首页|期刊导航|山东医药|人DNMT3A基因慢病毒载体构建及其乳腺癌细胞MDA-MB-231稳定表达株的建立

人DNMT3A基因慢病毒载体构建及其乳腺癌细胞MDA-MB-231稳定表达株的建立

张慧变 王媛 于林

山东医药2017,Vol.57Issue(42):5-8,4.
山东医药2017,Vol.57Issue(42):5-8,4.DOI:10.3969/j.issn.1002-266X.2017.42.002

人DNMT3A基因慢病毒载体构建及其乳腺癌细胞MDA-MB-231稳定表达株的建立

Construction of human DNMT3A lentiviral vector and establishment of stale MDA-MB-231 cell line

张慧变 1王媛 1于林1

作者信息

  • 1. 天津医科大学,天津300070
  • 折叠

摘要

Abstract

Objective To construct elentiviral vector of human DNA methyltransferase 3A(DNMT3A) and to es-tablish the stable breast caner MDA-MB-231 cell line.Methods The total RNA was extracted from MDA-MB-231cells and cDNA containing DNMT3A was inverse transcribed. DNMT3A fragment containing EcoRⅠand BamHⅠsites was am-plified by PCR and was inserted into pLVX-IRES-Hyg lentiviral vector. Then the recombinant expression vector pLVX-FLAG-DNMT3A was co-transfected into 293T cell line with packaging plasmids,and the culture supermatant containing the lentiviral particles was collected to infect MDA-MB-231 cells. After 48 h,1 μg/μpuromycin was used to screen the infec-ted cells,so as to obtain a cell line with stable expression. The protein and mRNA expression levels of DNMT3A were de-tected by Western blotting and PCR.Results Bacteria colonies PCR,double restriction enzyme digestion,plasmid PCR identification,and DNA sequencing demonstrated the lentiviral vector pLVX-FLAG-DNMT3A was constructed. MDA-MB-231 cells were infected by the lentivirus,and the protein and mRNA expression of DNMT3A was significantly up-regulated following screening with puromycin.Conclusions The DNMT3A gene lentiviral vector pLVX-FLAG-DNMT3A is con-structed successfully. The cell line stably expressing DNMT3A is screened in MDA-MB-231 cells,which provides an in vitro model for further study of molecular function and mechanism of DNMT3A in human breast cancer.

关键词

DNMT3A基因/慢病毒载体/MDA-MB-231细胞/乳腺癌

Key words

DNMT3A gene/lentiviral vector/MDA-MB-231 cells/breast carcinoma

分类

生物科学

引用本文复制引用

张慧变,王媛,于林..人DNMT3A基因慢病毒载体构建及其乳腺癌细胞MDA-MB-231稳定表达株的建立[J].山东医药,2017,57(42):5-8,4.

基金项目

国家自然科学基金资助项目(81672592,81202102). (81672592,81202102)

山东医药

OACSTPCD

1002-266X

访问量3
|
下载量0
段落导航相关论文